Impedimed (Australia) Today
| IPD Stock | 0.05 0 5.45% |
Performance2 of 100
| Odds Of DistressLess than 27
|
Impedimed is selling for under 0.052 as of the 27th of November 2024; that is 5.45 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.052. Impedimed has about a 27 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Impedimed are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 24th of October 2007 | Category Healthcare | Classification Health Care |
Impedimed is entity of Australia. It is traded as Stock on AU exchange. The company has 2.02 B outstanding shares. More on Impedimed
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Impedimed Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Impedimed's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Impedimed or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| MD CEO | Richard Valencia | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Care, Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care (View all Sectors) | ||||
Impedimed's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Impedimed's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsImpedimed can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Impedimed's financial leverage. It provides some insight into what part of Impedimed's total assets is financed by creditors.
| |||||
Impedimed (IPD) is traded on Australian Securities Exchange in Australia and employs 83 people. Impedimed is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 103.2 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Impedimed's market, we take the total number of its shares issued and multiply it by Impedimed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Impedimed operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 2.02 B outstanding shares.
Impedimed has accumulated about 13.55 M in cash with (17.79 M) of positive cash flow from operations.
Check Impedimed Probability Of Bankruptcy
Ownership AllocationImpedimed has a total of 2.02 Billion outstanding shares. Impedimed retains 9.07 (percent) of its outstanding shares held by insiders and 16.29 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Impedimed Ownership Details
Impedimed Risk Profiles
Although Impedimed's alpha and beta are two of the key measurements used to evaluate Impedimed's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.9 | |||
| Semi Deviation | 3.21 | |||
| Standard Deviation | 4.58 | |||
| Variance | 21.02 |
Impedimed Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Impedimed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
Impedimed Corporate Management
Elected by the shareholders, the Impedimed's board of directors comprises two types of representatives: Impedimed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Impedimed. The board's role is to monitor Impedimed's management team and ensure that shareholders' interests are well served. Impedimed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Impedimed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nancy Deisinger | VP HR | Profile | |
| Timothy Cruickshank | Chief Officer | Profile | |
| Shashi Tripathi | Chief Officer | Profile | |
| AAICD ACIS | Company Sec | Profile |
Additional Tools for Impedimed Stock Analysis
When running Impedimed's price analysis, check to measure Impedimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Impedimed is operating at the current time. Most of Impedimed's value examination focuses on studying past and present price action to predict the probability of Impedimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Impedimed's price. Additionally, you may evaluate how the addition of Impedimed to your portfolios can decrease your overall portfolio volatility.